Loading...

RSV

Human respiratory syncytial virus (RSV) is a syncytial virus that causes respiratory tract infections. It is a major cause of lower respiratory tract infections and hospital visits during infancy and childhood. A prophylactic medication, palivizumab, can be employed to prevent RSV in preterm (under 35 weeks gestation) infants, infants with certain congenital heart defects (CHD) or bronchopulmonary dysplasia (BPD), and infants with congenital malformations of the airway. Treatment is limited to supportive care (e.g. C-PAP), including oxygen therapy.

Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us

For research use only. Not intended for any clinical use.

© 2007 - 2020 Creative BioLabs All Rights Reserved
  • 0
  • 0

Cart